TRUPANION, INC.
TRUPNasdaq
$26.70
↑ +1.3%Jul 17 close · end-of-day
Price
1Y↓ -46.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.2B
Enterprise Value
$892.0M
P/E
45.3
P/S
0.8
P/B
3.0
EV/EBITDA
24.9
PEG
—
FCF Yield
6.4%
Dividend Yield
—
Revenue (TTM)
$1.5B
Net Income (TTM)
$19.4M
Free Cash Flow (TTM)
$75.1M
Gross Margin
—
Operating Margin
1.4%
Net Margin
1.3%
ROE
4.9%
ROIC
14.6%
Debt / Equity
0.3
Net Cash
$274.3M
Return 1Y
-47.4%
Company profile
Trupanion, Inc. provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
- CEO
- Darryl Rawlings
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Insurance
- Employees
- 1,130
- Headquarters
- Washington
- Website
- trupanion.com
Management & directors
- Gallagher John RChief Operating Officer
- Weinrauch SteveEVP, North Am & Vet Strategy
- Qureshi FawwadChief Financial Officer
- Bearman AsherChief Legal Officer
- Mcgibney BrennaChief Administration Officer
- Tooth MargaretCEO
- Wheeler SimonEVP, Trupanion International
- Dreyer EmilyChief Revenue Officer
Roles derived from SEC Form 4 filings.
Earnings
TRUP Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$384.0M↑ +12.3%
Diluted EPS$0.11↓ -466.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $502.0M | $699.0M | $905.2M | $1.1B | $1.3B | $1.4B |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$4.9M | -$35.2M | -$43.0M | -$40.7M | -$9.5M | $13.8M |
| Net income | — | -$35.5M | -$44.7M | -$44.7M | -$9.6M | $19.4M |
| Diluted EPS | -$0.16 | -$0.89 | -$1.10 | -$1.08 | -$0.23 | $0.45 |
| Operating cash flow | $21.5M | $7.5M | -$8.0M | $18.6M | $48.3M | $89.5M |
| Free cash flow | $14.1M | -$4.9M | -$25.1M | $358,000.00 | $38.6M | $75.4M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -1.0% | -5.0% | -4.8% | -3.7% | -0.7% | 1.0% |
| Net margin | — | -5.1% | -4.9% | -4.0% | -0.7% | 1.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $314.8M | $327.5M | $337.3M | $342.0M | $353.6M | $366.9M | $376.9M | $384.0M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$5.5M | $1.7M | $348,000.00 | -$1.5M | $2.3M | $5.9M | $7.1M | $4.8M |
| Net income | — | — | — | — | — | — | — | — |
| Diluted EPS | -$0.14 | $0.03 | $0.04 | -$0.03 | $0.22 | $0.13 | $0.13 | $0.11 |
| Operating cash flow | $6.9M | $15.3M | $23.7M | $16.0M | $15.0M | $29.2M | $29.3M | $14.6M |
| Free cash flow | $4.0M | $13.4M | $21.8M | $14.0M | $12.0M | $23.9M | $25.3M | $13.7M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -1.7% | 0.5% | 0.1% | -0.4% | 0.7% | 1.6% | 1.9% | 1.2% |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 16, 2026
Jul 14, 2026
Jul 13, 2026
Jul 9, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-29 | GALLAGHER JOHN R· Chief Operating Officer | Sale | 431 | $25.35 | $10,925.85 | filing |
| 2026-06-05 | WEINRAUCH STEVE· EVP, North Am & Vet Strategy | Sale | 6,674 | $22.00 | $146,828.00 | filing |
| 2026-06-05 | WEINRAUCH STEVE· EVP, North Am & Vet Strategy | Option exercise | 8,500 | $15.46 | $131,410.00 | filing |
| 2026-05-28 | GALLAGHER JOHN R· Chief Operating Officer | Sale | 3,603 | $21.69 | $78,153.39 | filing |
| 2026-05-27 | Qureshi Fawwad· Chief Financial Officer | Sale | 6,007 | $22.17 | $133,169.78 | filing |
| 2026-05-27 | Qureshi Fawwad· Chief Financial Officer | Sale | 170 | $22.63 | $3,846.25 | filing |
| 2026-05-25 | Qureshi Fawwad· Chief Financial Officer | Tax withholding | 1,497 | $21.86 | $32,724.42 | filing |
| 2026-05-25 | Tooth Margaret· CEO | Sale | 491 | $21.86 | $10,733.26 | filing |
| 2026-05-25 | MCGIBNEY BRENNA· Chief Administration Officer | Tax withholding | 180 | $21.86 | $3,934.80 | filing |
| 2026-05-25 | WHEELER SIMON· EVP, Trupanion International | Tax withholding | 150 | $21.86 | $3,279.00 | filing |
| 2026-05-25 | MCGIBNEY BRENNA· Chief Administration Officer | Tax withholding | 125 | $21.86 | $2,732.50 | filing |
| 2026-05-25 | GALLAGHER JOHN R· Chief Operating Officer | Tax withholding | 109 | $21.86 | $2,382.74 | filing |
| 2026-05-25 | WEINRAUCH STEVE· EVP, North Am & Vet Strategy | Tax withholding | 85 | $21.86 | $1,858.10 | filing |
| 2026-05-25 | BEARMAN ASHER· Chief Legal Officer | Tax withholding | 40 | $21.86 | $874.40 | filing |
| 2026-05-25 | MCGIBNEY BRENNA· Chief Administration Officer | Tax withholding | 16 | $21.86 | $349.76 | filing |
| 2026-05-25 | MCGIBNEY BRENNA· Chief Administration Officer | Tax withholding | 14 | $21.86 | $306.04 | filing |
| 2026-05-25 | GALLAGHER JOHN R· Chief Operating Officer | Tax withholding | 10 | $21.86 | $218.60 | filing |
| 2026-05-25 | MCGIBNEY BRENNA· Chief Administration Officer | Tax withholding | 9 | $21.86 | $196.74 | filing |
| 2026-05-25 | WEINRAUCH STEVE· EVP, North Am & Vet Strategy | Tax withholding | 9 | $21.86 | $196.74 | filing |
| 2026-05-25 | GALLAGHER JOHN R· Chief Operating Officer | Tax withholding | 7 | $21.86 | $153.02 | filing |
| 2026-05-25 | GALLAGHER JOHN R· Chief Operating Officer | Option exercise | 29 | — | — | filing |
| 2026-05-25 | Tooth Margaret· CEO | Option exercise | 1,250 | — | — | filing |
| 2026-05-25 | GALLAGHER JOHN R· Chief Operating Officer | Option exercise | 451 | — | — | filing |
| 2026-05-25 | MCGIBNEY BRENNA· Chief Administration Officer | Option exercise | 27 | — | — | filing |
| 2026-05-25 | GALLAGHER JOHN R· Chief Operating Officer | Option exercise | 45 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.